Abstract: Systems, methods, and software for filtering components, such as hardware components, compatible with computer-modeled structures are presented. A compatible components system provides selection methods that present components compatible with computer-aided design (CAD) models designed in computer modeling software. The system executes methods designed to filter components made available to designers using attribute information of the features and attribute information of the components. Designers may interact with the compatibility methods numerous times, narrowing components through a series or number of filtering steps until a desired compatible component is easily selected. The computer modeling software may include graphical user interfaces for selecting component source locations, filtering types of components presented by the system, and adding components to CAD models.

Abstract: Systems, methods, and software for filtering components, such as hardware components, compatible with computer-modeled structures are presented. A compatible components system provides selection methods that present components compatible with computer-aided design (CAD) models designed in computer modeling software. The system executes methods designed to filter components made available to designers using attribute information of the features and attribute information of the components. Designers may interact with the compatibility methods numerous times, narrowing components through a series or number of filtering steps until a desired compatible component is easily selected. The computer modeling software may include graphical user interfaces for selecting component source locations, filtering types of components presented by the system, and adding components to CAD models.

Abstract: The present invention provides a methods and compositions for treating a host afflicted with a viral infection, particularly a Flaviviridae infection, including hepatitis C infection, comprising administering an effective antiviral amount of a derivative of andrographolide alone or in combination or alternation with another antiviral compound.

Abstract: The present invention is a woodchuck or an isolated woodchuck cell infected with bovine viral diarrhea virus. The invention can be used to identify new compounds for the treatment of flavivirus, pestivirus or hepatitis C infection using these models.

Abstract: The present invention is a woodchuck or an isolated woodchuck cell infected with bovine viral diarrhea virus. The invention can be used to identify new compounds for the treatment of flavivirus, pestivirus or hepatitis C infection using these models.

Abstract: Classifying and processing post-consumer plastic scrap materials for subsequent utilization. Post-consumer plastic scrap of various kinds, such as colored HDPE, natural HDPE, green PET and clear PET are separating into constituent fractions, and each fraction is separately reduced to flakes. At least some of the fractions are separately washed to remove fragments of labels or other foreign matter previously in place on the plastic bottles or other containers making up those scrap constituents.

Abstract: A process and apparatus for receiving and reducing co-extruded car trim into chips and for separating the components of the chips into a metal fraction and a plastic fraction is provided; the chips are immersed in a heated liquid medium which subsequently separates the plastic from the metal with agitation and heat. The plastic and the metal are finally classified by their respective densities in a liquid upflow column.

Abstract: A method and apparatus for controlling a model based open-loop process and more specifically, the concentration of a drug delivered intravenously to a patient as a function of the rate of infusion. A three-compartment pharmacokinetic model is preferably used to determine the plasma drug concentrations corresponding to two arbitrarily selected rates of infusion. Based upon the linear relationship between corresponding data pairs, each pair comprising a rate of infusion and a corresponding plasma drug concentration, an interpolated rate is determined by a microprocessor (100) as a function of a specified plasma drug concentration, in accordance with program steps stored in a read only memory (ROM) 104. The actual infusion rate of the drug during successive time intervals is repetitively used to compute the plasma drug concentration at the end of each time interval.

Abstract: A composite static structure formed of interdependent subcomponents, referred to as simple tetrahypars, combined to achieve an independent structural component or tetrahypar. Each simple tetrahypar has two rigid struts spaced along and extending perpendicular to a common axis of twist and lying in planes that intersect along the axis. The struts are connected by a torsion member, called a twister, that extends along the axis of twist. One strut of one tetrahypar is connected between one set of ends of the two struts of the other tetrahypar, and the other strut of the one tetrahypar is connected between the other set of ends of the two struts of the other tetrahypar.